EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HBP ‐A Attenuates Knee Osteoarthritis Progression via MLK3 / P38 / HDAC4 Axis‐Mediated Dual Protection of Articular Cartilage and Quadriceps

Zhengming Wang, Junyan Huang, Yuanyuan Feng, Zhengyan Li, Haiya Ge, Rui Wang, Yong Gu, Yizhe Xiong, Bo Chen, Mingcai Zhang, Xiang Wang, Ying Shi und 3 weitere

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Zhengming Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Shi's Center of Orthopedics and Traumatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Cartilage, Articular, Histone Deacetylases, p38 Mitogen-Activated Protein Kinases, Osteoarthritis, Knee. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Health Commission, Zhangjiagang Science and Technology Bureau, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Knee osteoarthritis (KOA), a degenerative joint disease driven by biomechanical instability, involves cartilage degradation, muscle dysfunction, and MLK3/P38 MAPK pathway activation. Histone deacetylase 4 (HDAC4), a regulator of chondrocyte and muscle homeostasis, interacts with this pathway during disease progression. While Hyriopsis Bioactive Polysaccharide‐Anodonta (HBP‐A) exhibits P38 MAPK inhibitory properties in vitro, its in vivo therapeutic effects on musculoskeletal tissues remain uncharacterised. A destabilisation of the medial meniscus (DMM) mouse model was established to investigate HBP‐A's therapeutic potential. Animals were randomly divided into sham‐operated, DMM‐induced, and HBP‐A‐treated groups. Following surgical induction, HBP‐A (0.26 g/kg) was administered daily via oral gavage for 4 weeks. Comprehensive assessments included behavioural tests for pain sensitivity, micro‐CT scanning, histological evaluation, and transmission electron microscope. Molecular mechanisms were investigated via immunohistochemical or immunofluorescence staining of MLK3, P38 MAPK, Caspase‐3, and HDAC4, complemented by RT‐qPCR analysis of myokine expression. HBP‐A treatment significantly alleviated pain sensitivity compared to the DMM group. Structural evaluations revealed preserved subchondral bone integrity and attenuated cartilage degeneration, with histological scoring confirming reduced pathological changes. Quadriceps exhibited mitigated atrophy and restored ultrastructural organisation. Molecular profiling demonstrated suppressed MLK3/P38 MAPK pathway activation, diminished apoptotic activity, and elevated HDAC4 expression in both cartilage and quadriceps. HBP‐A additionally normalised dysregulated expression of muscle‐derived osteogenic factors linked to bone‐cartilage crosstalk. These findings establish HBP‐A as a dual‐target therapeutic agent for KOA, concurrently mitigating cartilage and muscle degeneration through MLK3/P38 MAPK/HDAC4 axis modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cartilage, ArticularHistone Deacetylasesp38 Mitogen-Activated Protein KinasesOsteoarthritis, KneeQuadriceps MuscleAnimalsMiceMaleDisease Models, AnimalDisease ProgressionSignal Transduction

Stichwörter der Autor:innen

Hyriopsis Bioactive Polysaccharide‐AnodontaMLK3/P38/HDAC4 axiscartilageosteoarthritisquadriceps

Substanzen

Histone Deacetylasesp38 Mitogen-Activated Protein KinasesHdac5 protein, mouse

Autor:innen und Institutionen

  • Shi's Center of Orthopedics and Traumatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Institute of Traumatology & Orthopedics, Shanghai Academy of Traditional Chinese Medicine, Shanghai, China.
  • Department of Medical Oncology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Orthopedic Surgery, Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China.
  • Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu, China.

ORCID-Profile: Hongsheng Zhan

Förderung

  • Shanghai Municipal Health Commission
  • Zhangjiagang Science and Technology Bureau
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Z., Huang, J., Feng, Y., Li, Z., Ge, H., Wang, R., Gu, Y., Xiong, Y., Chen, B., Zhang, M., Wang, X., Shi, Y., Shen, Z., Zhan, H., & Du, G. (2025). HBP ‐A Attenuates Knee Osteoarthritis Progression via MLK3 / P38 / HDAC4 Axis‐Mediated Dual Protection of Articular Cartilage and Quadriceps. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70577

Vancouver

Wang Z, Huang J, Feng Y, Li Z, Ge H, Wang R, et al. HBP ‐A Attenuates Knee Osteoarthritis Progression via MLK3 / P38 / HDAC4 Axis‐Mediated Dual Protection of Articular Cartilage and Quadriceps. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70577

BibTeX
@article{Wang2025,
  author = {Wang, Zhengming and Huang, Junyan and Feng, Yuanyuan and Li, Zhengyan and Ge, Haiya and Wang, Rui and Gu, Yong and Xiong, Yizhe and Chen, Bo and Zhang, Mingcai and Wang, Xiang and Shi, Ying and Shen, Zhibi and Zhan, Hongsheng and Du, Guoqing},
  title = {HBP ‐A Attenuates Knee Osteoarthritis Progression via MLK3 / P38 / HDAC4 Axis‐Mediated Dual Protection of Articular Cartilage and Quadriceps},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70577}
}
Kostenlos starten →